EGFR and non-small cell lung carcinoma: ,57,58,59 Interestingly, RB1 loss and MYC copy number gain were also negative clinical predictors for EGFR-mutant NSCLC, both in the adjuvant setting59 and in the metastatic resistant setting with an association of transformation to small cell lung cancer.60